Nirmaymed Pharma Private Limited
About Nirmaymed Pharma Private Limited
Data last updated:
Nirmaymed Pharma Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24239UP2016PTC086604. Its GSTIN is 09AAFCN3746G1ZB (Uttar Pradesh).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajeev Pahuja and Tarun Malik.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lower Ground Floor Hall Building No. 113/2/1/2/3 Naya Gaon (West) Aminabad, Lucknow, Uttar Pradesh, India – 226018.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.89 Cr, a growth of 74% compared to the previous year. For the same year it recorded a net profit of ₹45.22 Lakh (net margin 11.6%) and EBITDA of ₹67.95 Lakh (EBITDA margin 17.5%). Revenue has grown at a compounded annual rate (CAGR) of 18% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Nirmaymed Pharma Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressLower Ground Floor Hall Building No. 113/2/1/2/3 Naya Gaon (West) Aminabad, Lucknow, Uttar Pradesh, India – 226018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nirmaymed Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Nirmaymed Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Nirmaymed Pharma Private Limited, buy the company report.
Financials of Nirmaymed Pharma Private Limited
FY 2025 filings availableNirmaymed Pharma Private Limited reported revenue of ₹3.89 Cr (up 74% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 74% growth in the latest year. EBITDA rose 124% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹67.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹45.22 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.5% | ||||
| Net Profit Margin | 11.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nirmaymed Pharma Private Limited, buy the company report.
Board of directors of Nirmaymed Pharma Private Limited
Nirmaymed Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Pahuja | Director | 22 Sep 2016 | 10 Years 1 Months | Current |
| Tarun Malik | Director | 22 Sep 2016 | 10 Years 1 Months | Current |
Auditor
Nirmaymed Pharma Private Limited is audited by R M LALL & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R M LALL & CO | FY 2021 | 000932C |
Shareholding
The shareholding of Nirmaymed Pharma Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Nirmaymed Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nirmaymed Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nirmaymed Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nirmaymed Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCN3746G1ZB | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nirmaymed Pharma Private Limited, buy the company report.
Recent activity
Nirmaymed Pharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Rajeev Pahuja was appointed as Director on 22 Sep 2016.
Frequently asked questions
Nirmaymed Pharma is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 September 2016 (10+ years old) and is registered under CIN U24239UP2016PTC086604.
Nirmaymed Pharma has 2 current directors:
- Rajeev Pahuja - Director
- Tarun Malik - Director
The latest financial statements of Nirmaymed Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Nirmaymed Pharma is 09AAFCN3746G1ZB, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Nirmaymed Pharma is U24239UP2016PTC086604. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nirmaymed Pharma was incorporated on 22 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
Rajeev Pahuja was appointed as Director on 22 Sep 2016. Tarun Malik was appointed as Director on 22 Sep 2016.
The registered office of Nirmaymed Pharma is at Lower Ground Floor Hall Building No. 1132123 Naya Gaon West Aminabad, Lucknow, Uttar Pradesh, India – 226018.
Nirmaymed Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Nirmaymed Pharma is compliant as of 12 September 2026. The company is actively filing with the Registrar of Companies.